CCR5 blockade inflames antitumor immunity in BAP1-mutant clear cell renal cell carcinoma.
Quan ZhouYangyang QiZewei WangHan ZengHongyu ZhangZhaopei LiuQiuren HuangYing XiongJiajun WangYuan ChangQi BaiYu XiaYiwei WangLi LiuLe XuBo DaiJianming GuoYu ZhuWeijuan ZhangJiejie XuPublished in: Journal for immunotherapy of cancer (2021)
NCT01358721, CA209-009.